Background Placebo interventions can have meaningful effects for patients. However, little
is known about the circumstances of their use in clinical practice. We aimed to investigate to …

Purpose The development of life-threatening hyperkalemia poses a risk for patients with
chronic preterminal renal failure. Various therapeutic options have been suggested for …

During a two-year study, all spider bites recorded by Swiss primary care physicians were
reported to the Swiss Toxicological Information Centre and all collected spiders were identified. …

To test the hypothesis that elevated atrial natriuretic peptide (ANP) may be involved in altered
fluid homeostasis at high altitude, we examined 25 mountaineers at an altitude of 550 m …

Background Few studies have investigated whether patients and physicians differ in their
attitudes regarding placebo interventions in medical practice. Aim To compare the proportions …

To search for possible metabolic interactions of [alpha]-human-atrial natriuretic peptide ([alpha]
hANP), we evaluated in 20 normal subjects blood levels of [alpha] hANP, glucose, insulin…

An increase in body mass due to oedema has been previously described. The aim of this
study was to investigate a potential association between both fluid and electrolyte intake and …

Objective: The prevalence of exercise-associated hyponatremia (EAH) has mainly been
investigated in marathoners and Ironman triathletes. The aim of this study was to investigate the …

Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Plasma
immunoreactive atrial natriuretic peptide (irANP) levels, their chromatographic profile, …

Possible influences of posture or age on plasma immunoreactive atrial natriuretic peptide (irANP)
levels and potential correlates were assessed in 12 young (age+/-sem 24+/-1 year) …